![]() |
Volumn 34, Issue 3, 2007, Pages 221-223
|
Perifollicular pigmentation is the first target for topical vitamin C derivative ascorbyl 2-phosphate 6-palmitate (APPS): Randomized, single-blinded, placebo-controlled study [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ASCORBIC ACID DERIVATIVE;
ASCORBYL 2 PHOSPHATE 6 PALMITATE;
PLACEBO;
UNCLASSIFIED DRUG;
ADULT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIGITAL IMAGING;
DRUG MECHANISM;
DRUG TARGETING;
FACE;
FACE MALFORMATION;
FEMALE;
HUMAN;
LETTER;
MALE;
PERIFOLLICULAR PIGMENTATION;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
SKIN;
STATISTICAL ANALYSIS;
STUDENT T TEST;
THERAPY EFFECT;
TREATMENT DURATION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ADULT;
ASCORBIC ACID;
COSMETICS;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
SINGLE-BLIND METHOD;
SKIN PIGMENTATION;
|
EID: 33846807778
PISSN: 03852407
EISSN: 13468138
Source Type: Journal
DOI: 10.1111/j.1346-8138.2007.00256.x Document Type: Letter |
Times cited : (14)
|
References (6)
|